HEART AND LUNG THERAPIES
At Xenios, a Fresenius Medical Care company, we offer treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop intelligent technological solutions that can be vital for the survival of critically ill patients.
We offer solutions that combine both cardiac and pulmonary support on one single technological platform. It supports the gas exchange in the lungs and the cardiovascular system to keep patients alive. The physician thus gains more vital treatment time during diagnosis and therapy.
Xenios is part of Fresenius Medical Care, the world’s leading provider of products and services for people with renal diseases. We are complementing Fresenius Medical Care’s product portfolio in the field of intensive care and are continuing to shape the future of extracorporeal multi-organ support.
In our daily work, we share a passion for helping people. For patients. Worldwide. Every day.
SYNCHRONIZED CARDIAC SUPPORT
Synchronized Cardiac Support is a new mechanical circulatory support method that adapts to the patient’s heart rhythm.
Pulsatility is closer to human physiology than continuous flow. The therapeutic goals are myocardial recovery and adequate organ perfusion.
Novalung therapy allows to mitigate, prevent or replace mechanical ventilation by extracorporeal gas exchange. It enables caregivers to give the lung time to heal and change the therapy environment in the ICU – from CO2 removal to full oxygenation.
Our international clinical support team accompanies the clinical application of all Fresenius Medical Care Heart & Lung products.
These specialists, trained in intensive care, provide trainings on-site in hospitals or online, e.g. for initial applications of our products.
HEART & LUNG CAMPUS
LEARNING WITH XENIOS
LOOKING FOR FURTHER THERAPY- AND XENIOS PRODUCT INFORMATION?
Join our Heart & Lung Campus to explore various eLearnings, for example expert interviews, best-practice-cases, medical knowledge, hands-on-tutorials and priming instructions.
On demand, 24 hours a day, 7 days a week – whenever you need it.
Neonatal and pediatric ECMO with MiniLung petite kit
Fresenius Medical Care heart & lung launches patient kit, especially for neonatal and pediatric ECMO use Fresenius Medical Care’s heart & lung division Xenios AG introduced the MiniLung petite kit at ESICM LIVES congress this October. This patient kit was developed especially for neonatal and pediatric ECMO. Fresenius Medical Care’s ...
Fresenius Medical Care Heart & Lung enables ECMO simulation in virtual reality
VR app for extracorporeal heart and lung support at ESCIM LIVES 2022 Fresenius Medical Care’s heart & lung division Xenios AG presents its virtual reality application at ESCIM LIVES congress in Paris. Visitors can discover a fictitious ECMO case and interactive hands-on experiences. Fresenius Medical Care’s heart & lung division ...
Merger: Medos becomes fully integrated within Xenios
Medos Medizintechnik AG was merged into Xenios AG. This streamlines processes within the company and at the same time it grows closer to the parent company Fresenius Medical Care AG & Co. KGaA. Medos Medizintechnik AG (Medos) was founded in 1987 with a focus on cardiopulmonary solutions. Together with ...
21. – 24. March
42nd International Symposium on Intensive Care and Emergency Medicine
Visit our Critical Care booth!
30. March – 01. April
PICU NICU 2023
14th European Postgraduate Course in Neonatal and Pediatric Intensive Care Medicine
Visit our Heart & Lung booth!
University Children’s Hospital, Inselspital, Bern, Switzerland
26. – 29. April
11th EuroELSO (European Extracorporeal Life Support Organization) congress
Join our Heart & Lung symposium!
Visit our booth!
Centro Congressos de Lisboa, Lisbon, Portugal